As a leader in advancing research in oncology, BioLegend is proud to announce our partnership with The Parker Institute for Cancer Immunotherapy, a consortium of leading companies, nonprofits, and cancer centers, all coming together to maximize immunotherapy’s unique potential to tranform all cancers into manageable diseases, saving millions of lives.

The Parker Institute is an unprecedented effort to dramatically accelerate research breakthroughs and hasten the delivery of better treatments to patients.

As part of the Parker Institute, we will work together to enhance access to cutting edge tools and technology, and provide resources to help speed the discovery and development of treatment options.